{"id":7595,"date":"2024-11-11T13:06:42","date_gmt":"2024-11-11T10:06:42","guid":{"rendered":"https:\/\/iht.knu.ua\/en\/?p=7595"},"modified":"2024-11-11T13:06:42","modified_gmt":"2024-11-11T10:06:42","slug":"bring-your-research-to-life","status":"publish","type":"post","link":"https:\/\/iht.knu.ua\/en\/2024\/11\/11\/bring-your-research-to-life\/","title":{"rendered":"&#8220;Bring Your Research to Life!&#8221;"},"content":{"rendered":"<p>Starting from October 30, 2024, the immuno-biological company <a href=\"https:\/\/biopharma.ua\/\"><strong>Biopharma<\/strong><\/a> and <a href=\"https:\/\/www.preci.bio\/\"><strong>Preci<\/strong><\/a>, in collaboration with the <a href=\"https:\/\/iht.knu.ua\/\">Educational and Scientific Institute of High Technologies<\/a> at Taras Shevchenko National University of Kyiv, announce a competition for joint research projects for 2025. The competition is open to students, postgraduates, young scientists, and research groups from the Institute of High Technologies.<\/p>\n<p>Project proposals are accepted until December 30, 2024.<\/p>\n<p>Project Topics:<\/p>\n<p><strong>&#8220;Technology prototypes based on the latest advances in biology, biotechnology, and related sciences with potential practical applications in science and\/or industry.&#8221;<\/strong> Priority will be given to projects focusing on the development of analytical methods for proteins and nucleic acids, pharmacokinetics of high-molecular compounds, and disease modeling in vitro. Projects requiring in vivo research will not be considered.<\/p>\n<p>To participate, applicants must submit:<\/p>\n<p>&#8211; <a href=\"https:\/\/iht.knu.ua\/wp-content\/uploads\/2024\/10\/Research_Grants_form.pdf\">A completed application form<\/a> with brief project information;<br \/>\n&#8211; A project abstract in Ukrainian and English with signatures from the project leader and participants (1 copy);<br \/>\n&#8211; CVs in Ukrainian and English for the project leader (1 copy).<\/p>\n<p>The completed form, signed with the electronic signatures of participants and containing brief project information, should be sent to <a href=\"mailto:isvoiteshenko@knu.ua\">isvoiteshenko@knu.ua<\/a>. Only applications submitted in compliance with the stated requirements and within the deadline will be considered.<\/p>\n<p>Projects will be carried out at the R&amp;D departments of Biopharma\/Preci and the Institute of High Technologies (with detailed descriptions of available equipment and reagents provided separately). Additionally, Biopharma will allocate <strong>up to 400,000 UAH<\/strong> in scholarships per winning project. The project result should include a corresponding prototype and prepared materials for publication in a scientific journal indexed in Scopus\/Web of Science or for an international patent application. The project completion deadline is the end of 2025.<\/p>\n<p>Research may be conducted using the technical facilities of the <strong>Biopharma<\/strong> R&amp;D center.<\/p>\n<p>All paper documents must be compiled into one folder. Physical copies are accepted at the following address: Ukraine, 03023, Kyiv, 4G Glushkov Avenue, Room 216, Institute of High Technologies, Taras Shevchenko National University of Kyiv.<\/p>\n<p>Project leaders and main participants may submit multiple applications. However, funding will be awarded to only one project per leader.<\/p>\n<p><strong>For more details or inquiries, contact<\/strong> <a href=\"mailto:isvoiteshenko@knu.ua\">isvoiteshenko@knu.ua<\/a>, <strong>subject line: &#8220;2025 Project Competition.&#8221;<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Starting from October 30, 2024, the immuno-biological company Biopharma and Preci, in collaboration with the Educational and Scientific Institute of High Technologies at Taras Shevchenko National University of Kyiv, announce a competition for joint research projects for 2025. The competition<\/p>\n","protected":false},"author":6,"featured_media":7598,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5,6,15],"tags":[],"class_list":["post-7595","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-news_all","category-slider"],"acf":[],"_links":{"self":[{"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/posts\/7595"}],"collection":[{"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/comments?post=7595"}],"version-history":[{"count":2,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/posts\/7595\/revisions"}],"predecessor-version":[{"id":7599,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/posts\/7595\/revisions\/7599"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/media\/7598"}],"wp:attachment":[{"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/media?parent=7595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/categories?post=7595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/iht.knu.ua\/en\/wp-json\/wp\/v2\/tags?post=7595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}